BTK Inhibitors in Chronic Lymphocytic Leukemia
2 Views
administrator
07/08/23
Brad S. Kahl, MD, explores the most recent data surrounding the use of Bruton tyrosine kinase inhibitors acalabrutinib and zanubrutinib in chronic lymphocytic leukemia.
-
Category
Show more
Facebook Comments
No comments found